Creative Planning Cti Biopharma Corp Transaction History

Creative Planning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$1.02 - $2.15 $12,824 - $27,031	-12,573 Closed	0 $0
Q2 2020 Jul 23, 2020	SELL	$0.88 - $1.32 $33,000 - $49,500	-37,500 Reduced 74.89%	12,573 $15,000
Q4 2018 Feb 01, 2019	SELL	$0.73 - $2.19 $1,095 - $3,285	-1,500 Reduced 2.91%	50,073 $37,000
Q2 2018 Jul 20, 2018	SELL	$3.81 - $5.26 $3,905 - $5,391	-1,025 Reduced 1.95%	51,573 $257,000
Q1 2018 Apr 18, 2018	BUY	$2.7 - $4.06 $54,067 - $81,301	20,025 Added 61.48%	52,598 $205,000
Q3 2017 Oct 17, 2017	BUY	$3.12 - $3.65 $101,627 - $118,891	32,573	32,573 $104,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.